BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Behrouzi B, Araujo Campoverde MV, Liang K, Talbot HK, Bogoch II, McGeer A, Fröbert O, Loeb M, Vardeny O, Solomon SD, Udell JA. Influenza Vaccination to Reduce Cardiovascular Morbidity and Mortality in Patients With COVID-19: JACC State-of-the-Art Review. J Am Coll Cardiol 2020;76:1777-94. [PMID: 33032740 DOI: 10.1016/j.jacc.2020.08.028] [Cited by in Crossref: 13] [Cited by in F6Publishing: 23] [Article Influence: 6.5] [Reference Citation Analysis]
Number Citing Articles
1 van Laak A, Verhees R, Knottnerus JA, Hooiveld M, Winkens B, Dinant GJ. Impact of influenza vaccination on GP-diagnosed COVID-19 and all-cause mortality: a Dutch cohort study. BMJ Open 2022;12:e061727. [PMID: 36137620 DOI: 10.1136/bmjopen-2022-061727] [Reference Citation Analysis]
2 Bardaji A. Myocardial Injuries in COVID-19: More Questions Than Answers. JCM 2022;11:4527. [DOI: 10.3390/jcm11154527] [Reference Citation Analysis]
3 Maniar YM, Al-Abdouh A, Michos ED. Influenza Vaccination for Cardiovascular Prevention: Further Insights from the IAMI Trial and an Updated Meta-analysis. Curr Cardiol Rep 2022. [PMID: 35876953 DOI: 10.1007/s11886-022-01748-8] [Reference Citation Analysis]
4 Prabhakaran D, Singh K, Kondal D, Raspail L, Mohan B, Kato T, Sarrafzadegan N, Talukder SH, Akter S, Amin MR, Goma F, Gomez-mesa J, Ntusi N, Inofomoh F, Deora S, Philippov E, Svarovskaya A, Konradi A, Puentes A, Ogah OS, Stanetic B, Issa A, Thienemann F, Juzar D, Zaidel E, Sheikh S, Ojji D, Lam CSP, Ge J, Banerjee A, Newby LK, Ribeiro ALP, Gidding S, Pinto F, Perel P, Sliwa K. Cardiovascular Risk Factors and Clinical Outcomes among Patients Hospitalized with COVID-19: Findings from the World Heart Federation COVID-19 Study. Global Heart 2022;17:40. [DOI: 10.5334/gh.1128] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Chatterjee A, Saha R, Mishra A, Shilkar D, Jayaprakash V, Sharma P, Sarkar B. Molecular determinants, clinical manifestations and effects of immunization on cardiovascular health during COVID-19 pandemic era - A review. Current Problems in Cardiology 2022. [DOI: 10.1016/j.cpcardiol.2022.101250] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Behrouzi B, Bhatt DL, Cannon CP, Vardeny O, Lee DS, Solomon SD, Udell JA. Association of Influenza Vaccination With Cardiovascular Risk: A Meta-analysis. JAMA Netw Open 2022;5:e228873. [PMID: 35486404 DOI: 10.1001/jamanetworkopen.2022.8873] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
7 Liu R, Patel A, Du X, Liu H, Liu B, Wang C, Di Tanna GL. Association between influenza vaccination, all-cause mortality and cardiovascular mortality: a protocol for a living systematic review and prospective meta-analysis. BMJ Open 2022;12:e054171. [PMID: 35361644 DOI: 10.1136/bmjopen-2021-054171] [Reference Citation Analysis]
8 Rehati P, Amaerjiang N, Yang L, Xiao H, Li M, Zunong J, Wang L, Vermund SH, Hu Y. COVID-19 Vaccine Hesitancy among Adolescents: Cross-Sectional School Survey in Four Chinese Cities Prior to Vaccine Availability. Vaccines 2022;10:452. [DOI: 10.3390/vaccines10030452] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
9 Pankayatselvan V, Mukamal KJ. Influenza vaccination among adults with cardiovascular disease in the United States: Results from the Behavioral Risk Factor Surveillance System 2018-2019. Am Heart J 2022;244:50-3. [PMID: 34599883 DOI: 10.1016/j.ahj.2021.09.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
10 Shosha SH, Ajlan DI, Al-Ghatam R. Does influenza vaccination help reduce incidence of COVID-19 infection among hospital employees? Medicine (Baltimore) 2022;101:e28479. [PMID: 35029196 DOI: 10.1097/MD.0000000000028479] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Behrouzi B, Udell JA. Universal flu vaccines: a shot at lifelong cardioprotection? Nat Rev Cardiol 2022. [PMID: 35027698 DOI: 10.1038/s41569-021-00670-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
12 Guan Z, Chen C, Li Y, Yan D, Zhang X, Jiang D, Yang S, Li L. Impact of Coinfection With SARS-CoV-2 and Influenza on Disease Severity: A Systematic Review and Meta-Analysis. Front Public Health 2021;9:773130. [PMID: 34957025 DOI: 10.3389/fpubh.2021.773130] [Cited by in F6Publishing: 11] [Reference Citation Analysis]
13 Michos ED, Udell JA. Am I Getting the Influenza Shot Too?: Influenza Vaccination as Post-Myocardial Infarction Care for the Prevention of Cardiovascular Events and Death. Circulation 2021;144:1485-8. [PMID: 34723637 DOI: 10.1161/CIRCULATIONAHA.121.057534] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
14 Behrouzi B, Udell JA. Moving the Needle on Atherosclerotic Cardiovascular Disease and Heart Failure with Influenza Vaccination. Curr Atheroscler Rep 2021;23:78. [PMID: 34671861 DOI: 10.1007/s11883-021-00973-w] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Chen YL, Lin YJ, Chang YP, Chou WJ, Yen CF. Differences in Sources of Information, Risk Perception, and Cognitive Appraisals between People with Various Latent Classes of Motivation to Get Vaccinated against COVID-19 and Previous Seasonal Influenza Vaccination: Facebook Survey Study with Latent Profile Analysis in Taiwan. Vaccines (Basel) 2021;9:1203. [PMID: 34696311 DOI: 10.3390/vaccines9101203] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
16 Assis M, Simoes LGP, Tremiliosi GC, Ribeiro LK, Coelho D, Minozzi DT, Santos RI, Vilela DCB, Mascaro LH, Andrés J, Longo E. PVC-SiO2-Ag composite as a powerful biocide and anti-SARS-CoV-2 material. J Polym Res 2021;28. [DOI: 10.1007/s10965-021-02729-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
17 Taghioff SM, Slavin BR, Holton T, Singh D. Examining the potential benefits of the influenza vaccine against SARS-CoV-2: A retrospective cohort analysis of 74,754 patients. PLoS One 2021;16:e0255541. [PMID: 34343191 DOI: 10.1371/journal.pone.0255541] [Cited by in Crossref: 1] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
18 Zhou X, Ye Q. Cellular Immune Response to COVID-19 and Potential Immune Modulators. Front Immunol 2021;12:646333. [PMID: 33995364 DOI: 10.3389/fimmu.2021.646333] [Cited by in F6Publishing: 20] [Reference Citation Analysis]
19 Tong X, Xu X, Lv G, Wang H, Cheng A, Wang D, Fan G, Zhang Y, Li Y. Clinical characteristics and outcome of influenza virus infection among adults hospitalized with severe COVID-19: a retrospective cohort study from Wuhan, China. BMC Infect Dis 2021;21:341. [PMID: 33845787 DOI: 10.1186/s12879-021-05975-2] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
20 Watson A, Wilkinson TMA. Respiratory viral infections in the elderly. Ther Adv Respir Dis 2021;15:1753466621995050. [PMID: 33749408 DOI: 10.1177/1753466621995050] [Cited by in Crossref: 3] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
21 Matoba T. Influenza and Pneumococcal Vaccination in Coronary Artery Disease. J Atheroscler Thromb 2021;28:813-5. [PMID: 33551395 DOI: 10.5551/jat.ED160] [Reference Citation Analysis]
22 Patel MM, Uyeki TM. Influenza Vaccine for Patients With High-risk Cardiovascular Disease. JAMA 2021;325:33-5. [PMID: 33275140 DOI: 10.1001/jama.2020.23948] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
23 Vardeny O, Kim K, Udell JA, Joseph J, Desai AS, Farkouh ME, Hegde SM, Hernandez AF, McGeer A, Talbot HK, Anand I, Bhatt DL, Cannon CP, DeMets D, Gaziano JM, Goodman SG, Nichol K, Tattersall MC, Temte JL, Wittes J, Yancy C, Claggett B, Chen Y, Mao L, Havighurst TC, Cooper LS, Solomon SD; INVESTED Committees and Investigators. Effect of High-Dose Trivalent vs Standard-Dose Quadrivalent Influenza Vaccine on Mortality or Cardiopulmonary Hospitalization in Patients With High-risk Cardiovascular Disease: A Randomized Clinical Trial. JAMA 2021;325:39-49. [PMID: 33275134 DOI: 10.1001/jama.2020.23649] [Cited by in Crossref: 20] [Cited by in F6Publishing: 24] [Article Influence: 20.0] [Reference Citation Analysis]
24 Ferdinand KC, Nedunchezhian S, Reddy TK. The COVID-19 and Influenza "Twindemic": Barriers to Influenza Vaccination and Potential Acceptance of SARS-CoV2 Vaccination in African Americans. J Natl Med Assoc 2020;112:681-7. [PMID: 33276969 DOI: 10.1016/j.jnma.2020.11.001] [Cited by in Crossref: 13] [Cited by in F6Publishing: 26] [Article Influence: 6.5] [Reference Citation Analysis]
25 Arokiaraj MC. Correlation of Influenza Vaccination and the COVID-19 Severity. SSRN Journal. [DOI: 10.2139/ssrn.3572814] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Reference Citation Analysis]